Cargando…
198 Meta-analysis of Transgender Exclusion from PrEP Clinical Trials
OBJECTIVES/GOALS: To evaluate access to Pre-Exposure Prophylaxis (PrEP) medications for transgender individuals examining how systemic and sociocultural obstacles play a role. Additionally, analyzing the impact of trans-exclusion in clinical trials investigating PrEP efficacy on the trans-HIV care m...
Autor principal: | Lee, Jeremiah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129827/ http://dx.doi.org/10.1017/cts.2023.272 |
Ejemplares similares
-
216 Relationships Between Self-Perceived Risk of HIV, Behavioral Risk of HIV, and Self-Reported Pre-Exposure Prophylaxis (PrEP) Utilization Among Young Men Who Have Sex with Men of Color at Risk for HIV Infection: Findings From a Prospective Cohort Study
por: Warus, Jonathan, et al.
Publicado: (2023) -
138 What are the Risk Factors Affecting PrEP Utilization Among Black Cisgender Women Who Are At Higher Risk Of HIV Acquisition?
por: Mathurin, Alene, et al.
Publicado: (2022) -
3567 An Analysis of Current Trends in Inclusion of Historically Underrepresented Populations in Clinical Trials: Women and Geriatrics
por: Chen, Jacqueline, et al.
Publicado: (2019) -
177 Education and Its Effects on Barriers to Clinical Trial Participation in Alzheimer’s Disease Studies by Underrepresented Communities
por: Ziegler, Mallory, et al.
Publicado: (2023) -
2215 The value of storytelling in community stakeholder feedback for clinical and translational research
por: Novak, Laurie L., et al.
Publicado: (2018)